Wolverine Trading
BIOR

Wolverine Trading’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Wolverine Trading’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-293
Closed -$36K – 5432
2022
Q3 		$36K Buy
293
+101
+53% +$18.2K ﹤0.01% 4249
2022
Q2 		$33K Buy
+192
New +$40.5K ﹤0.01% 4161
2022
Q1 		– Sell
-483
Closed -$257K – 6861
2021
Q4 		$257K Buy
483
+374
+343% +$268K ﹤0.01% 4364
2021
Q3 		$29K Buy
+109
New +$46.7K ﹤0.01% 6103

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wolverine Trading's BIOR Position: Q4 2022 in Review

Wolverine Trading sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2022, closing a stake of 293 shares — an estimated $36K sold.

Wolverine Trading first reported a position in BIOR in Q3 2021 and held it in 4 quarters. The position peaked at $257K in Q4 2021. 42 funds tracked by Wall St. Rank hold BIOR as of Q4 2022.

  • Wolverine Trading reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 293 Biora Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $36K.
  • Wolverine Trading first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Wolverine Trading's Biora Therapeutics, Inc. Common Stock position peaked at $257K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.